Showing results (81-90 of 302) with videos related to
Sort By:
Pageof 31
Cancers|April 26, 2020
Primary Resistance to PD-1-Based Immunotherapy-A Study in 319 Patients with Stage IV MelanomaTeresa Amaral, Olivia Seeber, Edgar Mersi, et al.Diagnostics (Basel, Switzerland)|September 23, 2022
Development of a Hybrid-Imaging-Based Prognostic Index for Metastasized-Melanoma Patients in Whole-Body 18F-FDG PET/CT and PET/MRI DataThomas Küstner, Jonas Vogel, Tobias Hepp, et al.British Journal of Cancer|February 14, 2018
Clinical outcome of concomitant vs interrupted BRAF inhibitor therapy during radiotherapy in melanoma patientsMarkus Hecht, Friedegund Meier, Lisa Zimmer, et al.Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|April 28, 2016
Gebrauch von Komplementärmedizin bei Patienten mit metastasierendem Melanom unter Therapie mit Ipilimumab innerhalb einer klinischen StudieJutta Huebner, Peter Mohr, Jan-Christoph Simon, et al.Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|April 28, 2016
Use of complementary medicine in metastatic melanoma patients treated with ipilimumab within a clinical trialJutta Huebner, Peter Mohr, Jan-Christoph Simon, et al.Cancers|December 10, 2021
Association between Immune-Related Adverse Events and Survival in 319 Stage IV Melanoma Patients Treated with PD-1-Based Immunotherapy: An Approach Based on Clinical ChemistryLina María Serna-Higuita, Teresa Amaral, Andrea Forschner, et al.Cancers|June 2, 2021
Complete Metabolic Response in FDG-PET-CT Scan before Discontinuation of Immune Checkpoint Inhibitors Correlates with Long Progression-Free SurvivalTimo E Schank, Andrea Forschner, Michael Max Sachse, et al.Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|April 23, 2021
PET/CT in malignant melanoma: a two-tiered healthcare system? Updated healthcare situation regarding initial staging of malignant melanoma with PET/CTAntonia Matiszick, Charlyn Völker, Claus Garbe, et al.European Journal of Cancer (Oxford, England : 1990)|February 12, 2019
Impact of radiation, systemic therapy and treatment sequencing on survival of patients with melanoma brain metastasesRicarda Rauschenberg, Johannes Bruns, Julia Brütting, et al.European Journal of Cancer (Oxford, England : 1990)|May 28, 2023
Immune checkpoint inhibition in patients with NRAS mutated and NRAS wild type melanoma: a multicenter Dermatologic Cooperative Oncology Group study on 637 patients from the prospective skin cancer registry ADOREGAnne Zaremba, Peter Mohr, Ralf Gutzmer, et al.Pageof 31